Fig. 1From: Ten-year follow-up of sitagliptin treatment in patients with type 2 diabetes mellitusProgress of subjects through the study. In both the sitagliptin group and control group, all combination medications including oral glucose-lowering drugs and other medications (antihypertensives and antihyperlipidemic agents) remained unchanged throughout the entire duration of the studyBack to article page